TUESDAY, Oct. 8, 2024 (HealthDay News) — A recently approved targeted chemotherapy drug can significantly extend the lives of advanced breast cancer patients who have developed tumors in their brains, new clinical trial results show. On average, patients receiving the drug Enhertu (trastuzumab deruxtecan) survived more than 17 months withoutContinue Reading

SATURDAY, Oct. 5, 2024 (HealthDay News) — Breast cancer strikes 1 in 8 women in the United States, but being diagnosed with the disease can still make you feel alone. To cope with such devastating news, breast cancer surgeons from the American College of Surgeons (ACS) offer tips on navigatingContinue Reading